Automated Decapping/Capping of Screw Cap Tubes
Micronic has announced the launch of an Automatic Screw Cap DeCapper system. The next-generation Screw Cap DeCapper is an innovative, easy-to-use device that provides automated decapping/capping of screw cap storage tubes in 96-tube racks in portrait or landscape formats. The device is able to cap or decap 96 Screw Cap tubes, in rows of 8 or 12, in just 60 seconds.
The new device is able to provide an automated capping/decapping solution for Micronic screw cap tubes, screw caps and the recently introduced low profile screw caps. Micronic low profile screw caps provide an unmatchable solution for biobanks and other laboratory facilities that need a space saving solution for their long-term sample storage at low temperatures.
The Automatic Screw Cap DeCapper includes new features such as real-time process monitoring, and torque monitoring for optimal tube sealing, to enhance sample security. An innovative “secure mode” further enhances sample security by decapping and recapping only one row at a time, minimising the time a tube is open and eliminating the risk of cross contamination. This feature also enables the rows to be paused for “point-of-use” pipetting between capping and recapping, which is very useful for manual workflows. A new turntable allows tube racks to be turned after decapping for better positioning in pipetting workflows. A laser sensor on the Automatic Screw Cap DeCapper detects the tube height so that no adapters are needed for different tube sizes. The devices graphical touchscreen interface simplifies programming and it clearly displays tubes to be capped or recapped which makes the Screw Cap DeCapper very easy to operate.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.